Back
BioCryst Pharmaceuticals Stock Price Chart
Sponsored
BCRX
Sponsored
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
35
BCRX
BioCryst Pharmaceuticals
Last Price:
8.16
Seasonality Move:
-9.69%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCRX is experiencing selling pressure, which indicates risk of future bearish movement.
BioCryst Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.82 | Buy |
20-day SMA: | 8.08 | Sell |
50-day SMA: | 7.71 | Buy |
200-day SMA: | 6.17 | Buy |
8-day EMA: | 7.92 | Buy |
20-day EMA: | 7.94 | Buy |
50-day EMA: | 7.62 | Buy |
200-day EMA: | 6.76 | Buy |
BioCryst Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 52.47 | Buy |
Chaikin Money Flow: | -1073813 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.73 - 8.31) | Sell |
Bollinger Bands (100): | (5.79 - 7.89) | Buy |
BioCryst Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BioCryst Pharmaceuticals Stock
Is BioCryst Pharmaceuticals Stock a Buy?
- BioCryst Pharmaceuticals share price is 7.97 while BCRX 8-day simple moving average is 7.82, which is a Buy signal.
- The stock price of BCRX is 7.97 while BioCryst Pharmaceuticals 20-day SMA is 8.08, which makes it a Sell.
- BioCryst Pharmaceuticals 50-day simple moving average is 7.71 while BCRX share price is 7.97, making it a Buy technically.
- BCRX stock price is 7.97 and BioCryst Pharmaceuticals 200-day simple moving average is 6.17, creating a Buy signal.
BCRX Technical Analysis vs Fundamental Analysis
Sell
35
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals a Buy or a Sell?
-
BioCryst Pharmaceuticals stock is rated a Sell
The current BioCryst Pharmaceuticals [BCRX] share price is $7.97. The Score for BCRX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
BioCryst Pharmaceuticals Stock Info
Market Cap:
1.65B
Price in USD:
7.97
Share Volume:
1.67M
BioCryst Pharmaceuticals 52-Week Range
52-Week High:
8.88
52-Week Low:
4.03
Sell
35
BioCryst Pharmaceuticals (BCRX)
is a Sell
BioCryst Pharmaceuticals Share Price Forecast
-
What is the BioCryst Pharmaceuticals stock price today?
The BioCryst Pharmaceuticals stock price is 7.97 USD today. -
Will BCRX stock go up or go down?
BioCryst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is BioCryst Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioCryst Pharmaceuticals is overvalued.
Is BioCryst Pharmaceuticals Stock a Buy?
- BioCryst Pharmaceuticals share price is 7.97 while BCRX 8-day exponential moving average is 7.92, which is a Buy signal.
- The stock price of BCRX is 7.97 while BioCryst Pharmaceuticals 20-day EMA is 7.94, which makes it a Buy.
- BioCryst Pharmaceuticals 50-day exponential moving average is 7.62 while BCRX share price is 7.97, making it a Buy technically.
- BCRX stock price is 7.97 and BioCryst Pharmaceuticals 200-day simple moving average is 6.76, creating a Buy signal.
Fundamental Analysis of BioCryst Pharmaceuticals
Is BioCryst Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.23 per share.
Technical Analysis of BioCryst Pharmaceuticals
Should I short BioCryst Pharmaceuticals stock?
- BCRX Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting BioCryst Pharmaceuticals is a Buy
- BioCryst Pharmaceuticals Relative Strength Index (RSI) is 52.47, which suggest BioCryst Pharmaceuticals is overbought
- The Bollinger Bands (25) for BioCryst Pharmaceuticals is (7.73 - 8.31), which suggest BioCryst Pharmaceuticals is a Buy
- The Bollinger Bands (100) for BioCryst Pharmaceuticals is (5.79 - 7.89), which suggest BioCryst Pharmaceuticals is a Buy
* BioCryst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.